CureVac NV
NASDAQ:CVAC

Watchlist Manager
CureVac NV Logo
CureVac NV
NASDAQ:CVAC
Watchlist
Price: 2.74 USD -1.08% Market Closed
Market Cap: 614.6m USD
Have any thoughts about
CureVac NV?
Write Note

Wall Street
Price Targets

CVAC Price Targets Summary
CureVac NV

Wall Street analysts forecast CVAC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVAC is 7.87 USD with a low forecast of 2.53 USD and a high forecast of 16.8 USD.

Lowest
Price Target
2.53 USD
8% Downside
Average
Price Target
7.87 USD
187% Upside
Highest
Price Target
16.8 USD
513% Upside
CureVac NV Competitors:
Price Targets
IDYA
IDEAYA Biosciences Inc
109% Upside
4893
Noile-Immune Biotech Inc
158% Upside
4599
StemRIM Inc
96% Upside
4587
PeptiDream Inc
21% Upside
ARWR
Arrowhead Pharmaceuticals Inc
129% Upside
MREO
Mereo Biopharma Group PLC
116% Upside
2616
CStone Pharmaceuticals
30% Upside
SIGHT
Gensight Biologics SA
27% Upside

Revenue
Forecast

Revenue Estimate
CureVac NV

For the last 4 years the compound annual growth rate for CureVac NV's revenue is 33%. The projected CAGR for the next 3 years is 35%.

33%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CureVac NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
CureVac NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CVAC's stock price target?
Price Target
7.87 USD

According to Wall Street analysts, the average 1-year price target for CVAC is 7.87 USD with a low forecast of 2.53 USD and a high forecast of 16.8 USD.

What is CureVac NV's Revenue forecast?
Projected CAGR
35%

For the last 4 years the compound annual growth rate for CureVac NV's revenue is 33%. The projected CAGR for the next 3 years is 35%.

Back to Top